Skip to main content

Medical marijuana is ready for shipping is pictured January 21, 2016 at Tweed Inc., one of the marijuana producers lobbying the federal government.

Dave Chan/The Globe and Mail

Several licensed marijuana producers have penned a letter to Ottawa, urging the federal government to allow them to brand their products and provide medical cannabis on a tax-free basis.

The seven producers – Tilray, Tweed, Mettrum, CannTrust, Green Organic Dutchman Holdings, RedeCan Pharm and Delta 9 Bio-Tech – are lobbying the government ahead of the week of April 10, when legislation legalizing recreational use of the drug is expected to be introduced.

A federal task force has recommended requiring plain packaging for cannabis and advertising restrictions similar to those placed on the tobacco industry.

Story continues below advertisement

But in their letter, the licensed producers argue that preventing them from branding their products will make it tougher for them to compete with black market operations such as illegal dispensaries.

"Brands allow professional companies to separate themselves from less scrupulous competitors," says Brendan Kennedy, president of B.C.-based marijuana producer Tilray.

Some health advocates have argued that restricting branding and advertising is necessary in order to ensure that users are aware of possible health risks associated with the substance.

Another concern is that cannabis producers could use advertising to compel widespread usage of the drug, similar to what occurred with tobacco and alcohol in the past.

But the licensed producers say they aren't looking to lure people into consuming marijuana. Instead, they wish to use branding and in-store advertising to educate users about various strains and their impacts, according to the letter.

"No one in this industry is looking to repeat the same mistakes as tobacco or alcohol," says Kennedy. "No one wants to see a Joe Camel of this industry."

Cannabis producers also take issue with the tax force's recommendation that medical and recreational cannabis be taxed the same amount.

Story continues below advertisement

This would "unduly burden" medical cannabis patients, according to the companies, who argue that medical cannabis should be sold tax free.

"Other pharmaceutical products aren't taxed," says Kennedy.

Report an error
Comments

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff.

We aim to create a safe and valuable space for discussion and debate. That means:

  • All comments will be reviewed by one or more moderators before being posted to the site. This should only take a few moments.
  • Treat others as you wish to be treated
  • Criticize ideas, not people
  • Stay on topic
  • Avoid the use of toxic and offensive language
  • Flag bad behaviour

Comments that violate our community guidelines will be removed. Commenters who repeatedly violate community guidelines may be suspended, causing them to temporarily lose their ability to engage with comments.

Read our community guidelines here

Discussion loading ...

Due to technical reasons, we have temporarily removed commenting from our articles. We hope to have this fixed soon. Thank you for your patience. If you are looking to give feedback on our new site, please send it along to feedback@globeandmail.com. If you want to write a letter to the editor, please forward to letters@globeandmail.com.
Cannabis pro newsletter